Evonile Pharma Limited announced the voting results for a postal ballot conducted to seek shareholder approval for two items of special business. The remote e-voting period was from 9:00 AM IST on October 14, 2026, to 5:00 PM IST on November 12, 2026. The cut-off date for determining shareholder eligibility to vote was October 9, 2026. The company had a total of 39,691 shareholders on the record date.

Resolution Details and Voting Results

Item No. 1: Approval of Grant of Employee Stock Options

The resolution sought approval for "the grant of employee stock options, equal to or more than 1% of the issued capital of the Company to the identified employee under Employee Stock Option Scheme 2026." This was a Special Resolution. The promoters and promoter group were not interested in this resolution.

The resolution was passed with a requisite majority. The total number of votes polled was 18,081,451, representing 73.2315% of the total outstanding shares (24,690,797).

  • Total Votes in Favour: 18,043,455 (99.7899% of votes polled)
  • Total Votes Against: 37,996 (0.2101% of votes polled)
  • Promoter & Promoter Group Voting: 17,450,720 shares voted 100% in favour.
  • Public Institutions Voting: 608,636 votes polled (94.67% of their 642,900 shares held); 94.028% in favour, 5.972% against.
  • Public Non-Institutions Voting: 22,095 votes polled (0.335% of their 6,597,177 shares held); 92.541% in favour, 7.459% against.

Item No. 2: Approval for Creation of Charge on Company Assets

The resolution sought approval "to consider and approve the creation of charge on the assets of the Company under Section 180(1)(a)." This was a Special Resolution. The promoters and promoter group were not interested in this resolution.

The resolution was passed with a requisite majority. The total number of votes polled was 18,081,451, representing 73.2315% of the total outstanding shares.

  • Total Votes in Favour: 18,044,292 (99.7945% of votes polled)
  • Total Votes Against: 37,159 (0.2055% of votes polled)
  • Promoter & Promoter Group Voting: 17,450,720 shares voted 100% in favour.
  • Public Institutions Voting: 608,636 votes polled; 94.028% in favour, 5.972% against.
  • Public Non-Institutions Voting: 22,095 votes polled; 96.329% in favour, 3.671% against.

Scrutinizer's Report

S. N. Ananthasubramanian & Co., Company Secretaries (ICSI Unique Code: P1991MH040400), was appointed as the Scrutinizer on October 8, 2026. The Scrutinizer's report, dated November 13, 2026, confirmed that all votes cast were valid and that both special resolutions were passed with the requisite majority. The report was signed by Managing Partner S. N. Viswanathan (FCS: 13685).

Enclosures and Availability

The disclosure includes Annexure I (Voting Results) and Annexure II (Scrutinizer's Report). These documents have also been made available on the company's website at https://evonilepharma.com/annual-general-meeting/.